Autoantibodies as Potential Biomarkers for Breast Cancer
Author Information
Author(s): Zhong Li, Ge Kun, Zu Jin-chi, Zhao Long-hua, Shen Wei-ke, Wang Jian-fei, Zhang Xiao-gang, Gao Xu, Hu Wanping, Yen Yun, Kernstine Kemp H
Primary Institution: Hebei University College of Life Sciences
Hypothesis
Can the previously described technique of using autoantibodies as markers for early detection be applied to breast cancer?
Conclusion
Serum autoantibody profiling is a promising approach for early detection and diagnosis of breast cancer.
Supporting Evidence
- Three combined phage proteins achieved 80% sensitivity and 100% specificity in predicting breast cancer.
- The study identified six unique phage-expressed proteins associated with breast cancer.
- Autoantibodies can be detected in the blood earlier than traditional tumor markers.
Takeaway
Doctors can find signs of breast cancer by looking for specific antibodies in the blood, which can help catch the disease early.
Methodology
The study used a breast cancer cDNA T7 phage library to identify tumor-associated proteins and measured autoantibody reactivities in serum samples from breast cancer patients and normal individuals using ELISA.
Potential Biases
Potential bias in sample selection and the limited number of proteins tested may affect the generalizability of the findings.
Limitations
The study's predictive accuracy was decreased during leave-one-out validation, indicating a need for further refinement and testing.
Participant Demographics
87 breast cancer patients (11 stage I, 28 stage II, 48 stage III) and 87 age-matched and sex-matched normal controls.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website